Admission Date:  [**2200-6-2**]       Discharge Date:[**2200-7-8**]

Date of Birth:   [**2131-8-1**]       Sex:  F

Service:

DATE OF DISCHARGE:  Pending.

AGE:  68.

HISTORY OF THE PRESENT ILLNESS:  [**Known firstname 1743**] [**Last Name (NamePattern1) 1744**] is a
68-year-old female who was at acute rehabilitation at
[**Location (un) 38**] after having a right-sided knee replacement on
[**2200-5-6**].  The patient had been on antibiotics following her
knee replacement and had developed abdominal pain two weeks
prior to admission with diarrhea.  The patient was presumed
to have C. difficile and had been started on Flagyl.  She was
taken to the [**Hospital1 69**] Emergency
Department and on presentation she had a white blood cell
count of 25,000, large amounts of nausea, and fevers up to
101.0 degrees.  Of note, the patient had been on Flagyl since
[**5-21**], until the patient's presentation on [**2200-6-2**].

REVIEW OF SYSTEMS:  Review of systems was negative for
dysuria.

PAST MEDICAL HISTORY:  History was notable for the following:
1.  Osteoarthritis.
2.  Left sided breast cancer.
3.  Diverticulitis.
4.  Gastrointestinal bleed.
5.  Fibromyalgia.

MEDICATIONS ON ADMISSION:
1.  Coumadin.
2.  Vistaril.
3.  ....................
4.  Tamoxifen.
5.  Zoloft.
6.  Protonix.
7.  Ditropan.
8.  [**Doctor First Name **].
9.  Lasix.

ALLERGIES:  The patient is allergic to SULFA AND IBUPROFEN.

SOCIAL HISTORY:  The patient has no history of alcohol,
drugs, or smoking.

PHYSICAL EXAMINATION:  On presentation, the patient's
physical examination revealed the following:  Temperature
100.3, heart rate 109, blood pressure 149/74, respiratory
rate 18, oxygen saturation 97%.  She was ill-appearing on
presentation with a diffusely tender abdomen with positive
rebound and no guarding.  Stool was guaiac negative.

HOSPITAL COURSE:  The patient was then admitted medical
service initially for management of her presumed C. difficile
colitis.

The patient was admitted to the medical service
postoperatively and then was noted to have pleural effusion
and then underwent a thoracocentesis of her effusion.  On the
14th, the patient continued to have poor hospital course and
on [**2200-6-5**] due to difficult medical management of the
disease, surgical consultation was obtained and the patient
underwent a subtotal colectomy with ileostomy.

Regarding the patient's operation, please referred to
Dr. [**Name (NI) 1745**] operative note on [**2200-6-5**].  Postoperatively,
the patient was taken to the Medical Intensive Care Unit for
further management of her disease.  She underwent numerous
transfusion of fresh-frozen plasma.  The patient was
continued to be intubated.  The patient was managed in the
Medical Intensive Care Unit with bilateral chest tubes placed
while the patient was in the Medical Intensive Care Unit.
The patient continued to have high fevers.  Sputum culture
from [**2200-6-21**] demonstrated Methicillin-resistant
Staphylococcus aureus and transthoracic cardiac
echocardiogram demonstrated no pericardial effusion or no
obvious vegetations, while the patient continued to have
these fevers.  The patient was continued on Vancomycin and
continued to be intubated for a long period of time until
[**2200-6-25**] when the patient was extubated successfully.

Post extubation, the patient had difficulty with her voice
and swallowing, and she was deemed an aspiration risk, so
Dobbhoff was placed.  She was then transferred to the floor
and she continued to do well.  Chest tubes were removed, and
she stopped having fevers.  Physical therapy consultation was
obtained and the patient began to improved dramatically while
on the floor.  She remained afebrile with stable vital signs
with reasonable respiratory parameters, and she was continued
on tube feeds or Promote with fiber at a goal rate of 70 cc
per hour.

The patient will be discharged to a rehabilitation facility
on the following regimen:
1.  Lopressor 50 mg PO t.i.d.
2.  Ambien 10 mg PO q.h.s.
3.  Vancomycin 1 gram q.d.
4.  Heparin 5000 units subcutaneously b.i.d.
5.  Regular insulin sliding scale.
6.  Protonix 40 mg IV q.d.
7.  The patient will continue on her tube feeds, Promote with
fiber at 70 cc an hour.

FOLLOW-UP CARE:  The patient will followup with Dr. [**Last Name (STitle) 519**] in
one to two weeks.  The patient will followup with her primary
care physician at the time deemed appropriate by their
office.

OF NOTE:  Portions of this chart were not available during
this dictation.




                            [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 520**], M.D.  [**MD Number(1) 521**]

Dictated By:[**Name8 (MD) 522**]
MEDQUIST36

D:  [**2200-7-7**]  13:37
T:  [**2200-7-7**]  13:57
JOB#:  [**Job Number 1746**]
